
Prenetics Global Limited Warrant
PRENW
PRENW: Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.
moreShow PRENW Financials
Recent trades of PRENW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PRENW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on PRENW's company Twitter account
Number of mentions of PRENW in WallStreetBets Daily Discussion
Recent insights relating to PRENW
Recent picks made for PRENW stock on CNBC
ETFs with the largest estimated holdings in PRENW
Flights by private jets registered to PRENW